Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 50Triple Negative Breast Neoplasms 7Rectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Carcinoma, Intraductal, Noninfiltrating 6Lung Neoplasms 5Adenocarcinoma of Lung 5Breast Carcinoma In Situ 3Pancreatic Neoplasms 2Unilateral Breast Neoplasms 1Transsexualism 1Recurrence 1Piebaldism 1Neoplasm Micrometastasis 1Lymphedema 1Inflammatory Breast Neoplasms 1Gynecomastia 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Chordoma 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1Breast Cancer Female 1Anisomastia 1Anatomic Stage IV Breast Cancer AJCC v8 1Anatomic Stage II Breast Cancer AJCC v8 1Amenorrhea 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Zoledronic Acid 1Trastuzumab 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Indocyanine Green 1Fluorescence 1Epirubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm Micrometastasis × Mastectomy, Segmental × Clear all
NCT00242203 2013-08-13

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Washington University School of Medicine

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡